首页> 外文期刊>Clinical Pediatric Endocrinology >A Novel Deletion Mutation of SLC16A2 Encoding Monocarboxylate Transporter (MCT) 8 in a 26-year-old Japanese Patient with Allan-Herndon-Dudley Syndrome
【24h】

A Novel Deletion Mutation of SLC16A2 Encoding Monocarboxylate Transporter (MCT) 8 in a 26-year-old Japanese Patient with Allan-Herndon-Dudley Syndrome

机译:26岁的日本人Allan-Herndon-Dudley综合征的SLC16A2编码单羧酸转运蛋白(MCT)8的新型删除突变。

获取原文
       

摘要

Allan-Herndon-Dudley Syndrome (AHDS), an X linked condition, is characterized by congenital hypotonia that progresses to spasticity with severe psychomotor delays, in combination with altered thyroid hormone levels, in particular, high serum T3 levels. Recently, this disease was proved to be caused by mutations in SLC16A2 coding for the monocarboxylate thyroid hormone transporter 8 (MCT8). Here we describe a 26-year -old Japanese patient with AHDS who had deletion of exon 3 of SLC16A2.
机译:与X连锁的疾病是Allan-Herndon-Dudley综合征(AHDS),其特征是先天性肌张力低下,逐渐发展为痉挛,伴有严重的精神运动延迟,并伴有甲状腺激素水平的改变,特别是血清T3水平高。最近,已证明该疾病是由编码单羧酸甲状腺激素转运蛋白8(MCT8)的SLC16A2突变引起的。在这里,我们描述了一位患有AHDS的26岁日本患者,该患者的SLC16A2外显子3缺失。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号